BioWorld MedTech

Dec. 9, 2013

Boston Sci has favorable results for Precision Spectra SCS study

A study evaluating Boston Scientific's (Natick, Massachusetts) Precision Spectra Spinal Cord Stimulator (SCS), shows that the device provides highly significant pain relief three months after implantation. Read More

Life science VC funding seen falling behind overall funding growth rates

BSD begins selling MicroThermX microwave ablation in Turkey

Financings roundup: Physicians Trust prices 8.3M shares, seeks to raise more than $89 million

Grants roundup: QED program grants $600,000 to support four new technologies

Agreements/contracts: Boston Sci, Medicines Co. co-promote Premier stent

Med-tech Notes

Product briefs

MDD's Neurology Extra

Today's news in brief

BioWorld

BioWorld briefs for April 4, 2025.

Today's news in brief

BioWorld MedTech

BioWorld MedTech briefs for April 4, 2025.

Caution tape displaying US flag, tariffs

Biopharma exempt from US reciprocal tariffs, but not untouched

BioWorld

At first glance, it appears that biopharmaceuticals dodged the latest U.S. tariff bullet; med-tech, not so much. According to the executive order President Donald...

3D rendering of glucagon-like peptide 1 (GLP-1)

ADPD 2025: Unlocking GLP-1's potential in neurodegeneration

BioWorld

At the recently launched Alzheimer’s & Parkinson’s Diseases Conference held in Vienna, Lotte Bjerre Knudsen from Novo Nordisk A/S, who has extensive experience in...

Immune checkpoint inhibitors illustration of PD-1, CTLA-4 and PD-L1.

Checkpoint inhibitor journey traces Chinese firms’ path to global revenue

BioWorld

Chinese pharmaceutical companies are making significant inroads into the global oncology market, particularly with the development and approval of immune...